Product image of [18f] Fludeoxyglucose Ujv (Fludeoxyglucose (18f)) supplied by GNH India

[18f] Fludeoxyglucose Ujv

Active Ingredient:
Fludeoxyglucose (18f)
Origin:
EU

[18f] Fludeoxyglucose Ujv (Fludeoxyglucose (18f))

Fludeoxyglucose (18F) is a radiopharmaceutical used in PET imaging to observe metabolic processes in the body. It helps detect areas of abnormal metabolic activity for diagnostic purposes. Commonly used in oncology, cardiology, and neurology. Short half-life requires prompt imaging after administration.

Manufacturer / TM Owner

Ústav Jaderného Výzkumu Řež A.S

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Fludeoxyglucose (18F) is primarily used in positron emission tomography (PET) scans to assess metabolic activity in tissues. It helps identify cancerous cells, monitor treatment response, and evaluate brain function or heart perfusion. Often used when what is fludeoxyglucose (18f) used for includes detecting tumors or assessing neurological conditions.

Side Effects

  • After intravenous injection, Fludeoxyglucose (18F) distributes throughout the body, highlighting areas with higher glucose metabolism. Imaging typically occurs 30–60 minutes post-injection to capture metabolic patterns. The radiotracer emits positrons detected by the PET scanner to create detailed images of internal structures.

Precautions & Warnings

  • Fludeoxyglucose (18F) should only be handled and administered by trained medical professionals in controlled settings. Patients may need to fast before the scan to ensure accurate results. Pregnant or breastfeeding individuals should inform their healthcare provider due to radiation exposure risks.

Avoid Interactions

  • No direct drug interactions are reported with Fludeoxyglucose (18F), but medications affecting glucose metabolism may influence scan outcomes. Patients should disclose all medications, including insulin or steroids, to their healthcare provider. Alcohol and caffeine consumption may also impact imaging results.

Frequently Asked Questions

It is used in PET scans to detect abnormal metabolic activity, often for cancer diagnosis or neurological assessment.

The scan itself typically lasts 20–40 minutes, but preparation and imaging may require 1–2 hours total.

Patients are usually advised to fast for 4–6 hours prior to the scan to improve image accuracy.

Radiation exposure poses potential risks, so pregnant individuals should consult their doctor before the procedure.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Fludeoxyglucose (18f)

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT